MEDA | 7,485 Euro | -0,031 -0,41 % | |
| WKN: 935166 ISIN: SE0000221723 Ticker-Symbol: M5E | Frankfurt | 25.05.12 | 17:50 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 21.05. | BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. | 39 | PR Newswire | |
| RALEIGH, N.C., May 21, 2012 /PRNewswire/ --BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced receipt of a pre-launch milestone payment of $2.5 million from Meda in conjunction with... Mehr lesen zu: BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. | ||||
| 10.05. | XETI DIVIDEND INFORMATION - 10.05.2012 - 2 | 357 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 10.05.2012 EX DIVIDENDE GEHANDELT.
THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 10.05.2012.
INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT
RNL XETI FR0000131906... Mehr lesen zu: XETI DIVIDEND INFORMATION - 10.05.2012 - 2 | ||||
| 10.05. | XFRA DIVIDEND INFORMATION - 10.05.2012 - 5 | 482 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 10.05.2012 EX DIVIDENDE GEHANDELT.
THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 10.05.2012.
INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT
ALU XFRA US0138171014... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 10.05.2012 - 5 | ||||
| 09.05. | Meda AB (publ) AGM bulletin | 36 | Business Wire | |
| Regulatory News:
At the annual general meeting (AGM) on May 9, 2012, of Meda AB
(publ)(STO:MEDAA), corporate ID 556427-2812, Box 906, SE-170 09 Solna,
... Mehr lesen zu: Meda AB (publ) AGM bulletin | ||||
| 09.05. | Meda AB (Publ) – Interim Report, January-March 2012 | 52 | Business Wire | |
| Regulatory News:
Meda AB(STO:MEDAA):
Group net sales reached SEK 3,375 million (2,944). At fixed currency
rates, sales increased... Mehr lesen zu: Meda AB (Publ) – Interim Report, January-March 2012 | ||||
| 09.05. | XETI DIVIDEND INFORMATION - 10.05.2012 - 1 | 72 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 09.05.2012 CUM DIVIDENDE UND AM 10.05.2012
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 09.05.2012. THE
EX-DIVIDEND DAY WILL BE 10.05.2012.
... Mehr lesen zu: XETI DIVIDEND INFORMATION - 10.05.2012 - 1 | ||||
| 09.05. | XFRA DIVIDEND INFORMATION - 10.05.2012 - 2 | 363 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 09.05.2012 CUM DIVIDENDE UND AM 10.05.2012
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 09.05.2012. THE
EX-DIVIDEND DAY WILL BE 10.05.2012.
... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 10.05.2012 - 2 | ||||
| 04.05. | MEDA: Dymista – could be the drug of choice | 35 | Business Wire | |
| Regulatory News:
Meda AB (STO:MEDAA):
The renowned Journal of Allergy and Clinical Immunology
((JACI;2012;129:1282–9) published an article... Mehr lesen zu: MEDA: Dymista – could be the drug of choice | ||||
| 02.05. | MEDA: Dymista approved by the FDA | 60 | Business Wire | |
| Regulatory News:
The U.S. Food and Drug Administration (FDA) has approved Dymista, a new
patented product for treatment of seasonal allergic rhinitis (SAR).... Mehr lesen zu: MEDA: Dymista approved by the FDA | ||||
| 17.04. | Maria Carell Declines Re-Election to the Board of Meda | 63 | Business Wire | |
| Regulatory News:
Maria Carell (STO:MEDAA), board member of Meda AB since 2011, has
informed Meda's nomination committee that she declines re-election at
... Mehr lesen zu: Maria Carell Declines Re-Election to the Board of Meda | ||||
| 17.04. | MEDA: Maria Carell Appointed Regional Director for the US | 71 | Business Wire | |
| Regulatory News:
Maria Carell has been appointed Regional Director for Meda's (STO:MEDAA)
operations in the US. Maria Carell has extensive experience in the... Mehr lesen zu: MEDA: Maria Carell Appointed Regional Director for the US | ||||
| 05.04. | Pharma-Branche: Leiter Recht für Novartis Consumer Health kommt von Meda | 21 | JUVE | |
| 03.04. | Meda AB (publ) Notice of Annual General Meeting 2012 | 31 | Business Wire | |
| Regulatory News:
Notice is hereby given that the Annual General Meeting (AGM) of Meda AB
(STO:MEDAA), corporate ID 556427-2812, will be held at 5.00 PM on... Mehr lesen zu: Meda AB (publ) Notice of Annual General Meeting 2012 | ||||
| 03.04. | Meda Expands Presence in Asia | 54 | Business Wire | |
| Regulatory News:
Meda (STO:MEDAA) has established an affiliate in Hong Kong. At the end
of last year, Meda opened its China affiliate based in Beijing. Meda... Mehr lesen zu: Meda Expands Presence in Asia | ||||
| 23.03. | MEDA: Nomination Committee's Proposal to Composition of the Board | 93 | Business Wire | |
| Regulatory News:
The Nomination Committee of Meda AB (STO:MEDAA) proposes the election of
Lars Westerberg as new board member. The committee also proposes... Mehr lesen zu: MEDA: Nomination Committee's Proposal to Composition of the Board | ||||
| 20.03. | MEDA: Astepro Approved in Europe | 40 | Business Wire | |
| Regulatory News:
Astepro (STO:MEDAA) has received registration approval in Europe via the
decentralized procedure. Astepro is a new nasal spray for the treatment... Mehr lesen zu: MEDA: Astepro Approved in Europe | ||||
| 05.03. | MEDA: Positive results for Dymista in three clinical studies | 86 | Business Wire | |
| Regulatory News:
Meda (STO:MEDAA) announced today positive results of three studies of
MP29-02 (tentatively called Dymista), a novel intranasal formulation... Mehr lesen zu: MEDA: Positive results for Dymista in three clinical studies | ||||
| 17.02. | Meda AB (publ) – Year-end report 2011 | 70 | Business Wire | |
| Regulatory News:
MEDA (STO:MEDAA):
· Group net sales reached SEK 12,856 million (11,571). At fixed currency
rates, sales increased 18%.
... Mehr lesen zu: Meda AB (publ) – Year-end report 2011 | ||||
| 23.01. | Perrigo (PRGO) Files ANDA for Generic Astepro Nasal Spray; Meda Pharma Files Patent Suit | 2 | StreetInsider.com | |
| 23.01. | Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals | 61 | PR Newswire | |
| ALLEGAN, Mich., Jan. 23, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug... Mehr lesen zu: Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
